Delivery Order 36F79720D0189-36C24121F0092
Award Date 12/21/20
Potential Completion Date 9/30/22
Potential Value $13K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Liberty Township, OH 45069, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Veterans Affairs Veterans Health Administration awarded Incyte Corporation a $556.97 million firm fixed price delivery order against their Pharmaceuticals and Drugs GSA Schedule contract. This order is to provide PEMAZYRE 9MG tablets to VHA facilities in Veterans Integrated Service Network 15. The place of performance is Incyte's location in Talleyville, Delaware and the period of performance runs from November 2020 through November 2021. No set aside designation or...
- Incyte Corporation was awarded a $12,725.23 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12. The delivery order, which has no set aside designation and completion date of October 30, 2020, is for the provision of PEMAZYRE to treat patients. The firm fixed price order was awarded on October 5, 2020 under Incyte's master GSA Schedule contract vehicle. The place...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1 awarded a $63,626.15 delivery order to Incyte Corporation under the Pharmaceuticals and Drugs Federal Supply Schedule. The firm fixed price order is for PEMAZYRE 13.5, with performance in West Haven, Connecticut and a completion date of April 10, 2022. The contract utilizes Master GSA Schedule FSS-61-IB and has no set-aside designation. Incyte will provide cancer treatment drugs to support...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded Incyte Corporation a $12,873.68 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule contract to provide PEMIGATINIB/PEMAZYRE 4.5MG tablets. The order was awarded on May 2, 2023 with a completion date of June 2, 2023 and utilizes firm fixed pricing. Performance will take place in Talleyville, Delaware. No set-aside designation was applied to this order to...
- Incyte Corporation was awarded a $12,725.23 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12. The firm fixed price order is for the drug PEMAZYRE and has a completion date of December 31, 2020. The contract was awarded on November 18, 2020 and utilizes Master Schedule contract FSS-61-IB, which provides pharmaceuticals and drugs to government agencies. The...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded a $12,725 delivery order against Incyte Corporation's Pharmaceuticals and Drugs GSA Schedule contract number FSS-61-IB. This firm fixed price order is to provide PEMIGATINIB/PEMAZYRE 4.5MG tablets for use in VA's healthcare programs from November 3rd to December 4th, 2023. Place of performance will be Incyte's facility in Talleyville, Delaware. No subcontractors or set aside...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded Incyte Corporation a $12,725.23 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule contract to provide 13.5mg tabs of pemigatinib (Pemazyre). Performance will occur in Talleyville, Delaware by the fixed price completion date of November 15, 2020. The delivery order was awarded on October 29, 2020 with no set-aside designation specified. Pemazyre will be...
- This delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule, awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12, is for $12,725.23 worth of Pemazyre 13.5mg to Incyte Corporation for delivery by October 10, 2020. The firm fixed price order was awarded on September 10, 2020 to the prime contractor Incyte Corporation for emergency provision of the pharmaceutical to an unspecified VA medical facility located in...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded a $12,873.68 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule contract to Incyte Corporation. The firm fixed price order is for the provision of PEMIGATINIB (PEMAZYRE) 4.5MG tablets to the VA medical center located in Talleyville, Delaware, with performance taking place from July 28, 2023 through September 28, 2023. As the prime contractor, Incyte will...
- Incyte Corporation has been awarded a $12,811.62 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21. The firm fixed price order is for PEMIGATINIB/PEMAZYRE 9MG TAB to be delivered to a location in Fresno, California by May 22, 2023. No set-aside designation was applied to this order placed under GSA Schedule FSS-61-IB to supply pharmaceutical products and drugs in...